Glucosidase

Glucosidase refers to a group of carbohydrate-active enzymes that hydrolyze glycosidic bonds in glucosides and oligosaccharides, producing glucose or other sugar residues. The term includes enzymes with different substrate specificities and stereochemical preferences, particularly α-glucosidases and β-glucosidases, which act on α- or β-linked glucose-containing substrates, respectively. Glucosidases are found in animals, plants, fungi, and microorganisms and participate in carbohydrate digestion, intracellular glycan processing, biomass degradation, and carbohydrate metabolism.

In human physiology, intestinal α-glucosidase activity contributes to the final stages of starch and disaccharide digestion by releasing glucose for absorption. Pharmacological inhibition of α-glucosidase can delay carbohydrate breakdown and glucose absorption, thereby reducing postprandial blood-glucose excursions. This mechanism has made α-glucosidase an established target in research on type 2 diabetes, often alongside amylase, which catalyzes earlier stages of starch hydrolysis. Acarbose is a commonly used reference inhibitor in biochemical and drug-discovery studies, while metformin has also been investigated for possible competitive interactions with α-glucosidase. Inhibitor discovery commonly uses enzyme-kinetic analysis, IC50 measurements, molecular docking, and assessment of hydrophobic interactions and hydrogen bonding.

Beyond diabetes research, glucosidases are being explored as targets for carbohydrate-processing technologies and enzyme-activated therapeutics. Selective enzymatic activation has, for example, been investigated as a means of triggering controlled radical release, while simultaneous inhibition of α- and β-glucosidase and amylase has been evaluated in experimental anticancer strategies.